Find Research Outputs

Search results

• A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

  Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.

  Research output: Contribution to journal › Article › peer-review

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one
  • gemcitabine
  • Multicenter Studies
  • Adenocarcinoma
  • Placebos
  2 Scopus citations

• A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

  Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 1 2011, In: Investigational New Drugs. 29, 3, p. 489-498 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Ipilimumab
  • Dacarbazine
  • Multicenter Studies
  • Melanoma
  • Drug Therapy
  224 Scopus citations

• Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

  MMAIT-IV Clinical Trial Group, Dec 1 2017, In: Annals of Surgical Oncology. 24, 13, p. 3991-4000 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Mycobacterium bovis
  • Immunotherapy
  • Melanoma
  • Neoplasm Metastasis
  • Survival
  39 Scopus citations